mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels

P.Cohen; I.Bieche; J.Vendrell; C.Keime; R.Lidereau; C.Dumontet; S.Ghayad

首页> 外文期刊>European Journal of Cancer Supplements >mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels

【24h】

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels

机译：mTOR抑制在细胞增殖和基因表达水平上逆转乳腺癌细胞获得性内分泌治疗的耐药性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第9期|共1页
作者
P.Cohen; I.Bieche; J.Vendrell; C.Keime; R.Lidereau; C.Dumontet; S.Ghayad;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. [J] . Ghayad SE, Bieche I, Vendrell JA, Cancer science. . 2008,第10期

机译：在细胞增殖和基因表达水平上，mTOR抑制可逆转乳腺癌细胞获得性内分泌治疗的耐药性。
2. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels [J] . P.Cohen, I.Bieche, J.Vendrell, European Journal of Cancer Supplements . 2008,第9期

机译：mTOR抑制在细胞增殖和基因表达水平上逆转乳腺癌细胞获得性内分泌治疗的耐药性
3. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. [J] . Saleh EM, El Awady RA, Abdel Alim MA Cell biochemistry and biophysics . 2009,第2期

机译：增殖诱导和增殖抑制基因表达的改变可能有助于乳腺癌细胞获得性阿霉素抗性。
4. Effect of Inhibition of DLC-1 Gene Expression by RNA Interference (RNAi) on Cell Proliferation and Migration in Colon Cancer LoVo Cell Line [C] . Peiling Huang, Yueling Jin, Xiaoqiang Tian, International Forum on Progress on Post-Genome Technologies(5'IFPT); 20070910-11; Suzhou(CN) . 2007

机译：RNA干扰（RNAi）抑制DLC-1基因表达对结肠癌LoVo细胞株细胞增殖和迁移的影响
5. PC cell derived growth factor (PCDGF/granulin precursor) expression, antiestrogen resistance and tumorigenesis in human breast cancer cells. [D] . Tangkeangsirisin, Wisit. 2004

机译：人乳腺癌细胞中PC细胞衍生的生长因子（PCDGF /颗粒蛋白前体）的表达，抗雌激素性和肿瘤发生。
6. Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells [O] . Kumiko Oida, Akira Matsuda, Kyungsook Jung, -1

机译：核因子-ĸB在人类乳腺癌细胞内分泌治疗和获得性耐药中均起着关键作用
7. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels [O] . Sandra E. Ghayad, Ivan Bieche, Julie A. Vendrell, 2008

机译：MTOR抑制反转在细胞增殖和基因表达水平下获得乳腺癌细胞的内分泌治疗抗性
8. Inhibition of Estrogen Receptor Coactivator Expression by Antisense Oligodeoxynucleotides and Effect on Breast Cancer Cell Proliferation and Gene Expression [R] . Smith, C. L. 2003

机译：反义寡核苷酸对雌激素受体辅激活因子表达的抑制作用及对乳腺癌细胞增殖和基因表达的影响

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels

著录项

相似文献

相关主题

期刊订阅